share_log

Citigroup Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $12.5

Citigroup Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $12.5

花旗集团对Sabra Health Care REIT保持中立,将目标股价上调至12.5美元
Benzinga ·  2023/07/14 11:32

Citigroup analyst Nicholas Joseph maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $11 to $12.5.

花旗集团分析师Nicholas Joseph维持Sabra Health Care REIT(纳斯达克:SBRA)的中性,并将目标价从11美元上调至12.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发